Keeping Up with the Diabetes Technology: 2016 Endocrine Society Guidelines of Insulin Pump Therapy and Continuous Glucose Monitor Management of Diabetes

2017 ◽  
Vol 17 (11) ◽  
Author(s):  
Alfonso Galderisi ◽  
Elise Schlissel ◽  
Eda Cengiz

Diabetes tsunami has hit India in a very devastating way in last decade. There is no doubt that CSII with Insulin pump Therapy has proved superior to MDI (multiple Dose Injection) therapy in Type1DM as well as Type2DM patients. Economics has been a very important issue while advocating the Pump to either patients, type 1 or type 2 Diabetes Mellitus patients. Out of 9 (Nine) patients using Insulin Pumps in our centre GANDHI CLINIC, PUNE, INDIA there are 5 Type 2 patients and 4 Type 1DM patients. Two Pumps are deposited at my Clinic due to the sad demise of the Type2DM patients. The relatives of these patients do wish to sell these pumps with some depreciation price i.e. at lower price than the new one. One patient (type2DM) has stopped using the Insulin pump due to the adverse advice from another healthcare provider who also wants to sell the pump at some discounted price. As per my survey in the Metro city of Pune (INDIA) approximately 700 insulin pumps are sold, out of these at least 5-7% of total pumps are not being used anymore. The unused pumps are at least 50 in number. Therefore revenue in terms of PUMPS in one region of INDIA is about 70000 US Dollars. Total number of pumps used in INDIA is 70000-72000 pumps approx. The total unused pumps by the patients could be about 3000 to 5000 pumps in total and thereby the revenue loss in this resource constrained country could be in millions of Dollars. This scenario is probably the same scene in many developing countries wherein the healthcare budgets are limited. In INDIA, Insulin Pump Therapy is not yet covered by Insurance policy of the patients. Since the pumps are usually purchased thru pocket expenses or with Loan or selling some assets like land or Gold, the relatives of the patients are not wrong in expecting some financial recovery after losing the most important thing i.e. the PERSON or even if patient does not want to continue the use of pump due to any reason. We do see refurbished cars sold and there are eligible and deserving candidates available who cannot purchase a new model of the Car. I am sure INDIA is an important market of Diabetes Technology related Products like Insulin Pump, similar to the many developing countries. This article is aimed at KOLs in Dialectology and Economists in the world for a basic policy change in favour of the patient care.


2021 ◽  
pp. 193229682110286
Author(s):  
Marie Auzanneau ◽  
Joachim Rosenbauer ◽  
Werner Maier ◽  
Simone von Sengbusch ◽  
Johannes Hamann ◽  
...  

Background: Despite increasing use of technology in type 1 diabetes, persistent ethnic and socio-economic disparities have been reported. We analyzed how the use of insulin pump therapy and continuous glucose monitoring (CGM) evolved over the years in Germany depending on demographics and area deprivation. Method: We investigated the use of insulin pump and CGM between 2016 and 2019 in 37,798 patients with type 1 diabetes aged < 26 years from the German Prospective Follow-up Registry (DPV). Associations with federal state, area-deprivation quintile (German Index of Multiple Deprivation 2010 on district level), gender, and migration background were investigated over time using multiple logistic regression. Results: Between 2016 and 2019, the regional distribution of insulin pump use did not change substantially and the association with area deprivation remained non-linear and statistically non-significant. The effect of area deprivation on CGM use decreased continuously and disappeared in 2019 (OR [95%-CI] Q1 vs Q5: 1.85 [1.63-2.10] in 2016; 0.97 [0.88-1.08] in 2019). The effect of migration background on the use of either technology decreased over the years but remained significant in 2019. Girls had constantly higher odds of using an insulin pump than boys (OR: 1.25 [1.18-1.31] in 2019), whereas no gender difference was identified for CGM use. Conclusions: Although disparities decreased in Germany, access to diabetes technology still depends on migration background in 2019, and gender differences in pump use persist. As technological advances are made, further research is needed to understand the reasons for these persistent disparities.


2018 ◽  
Vol 18 (2) ◽  
pp. 69-70 ◽  
Author(s):  
Emma G Wilmot ◽  
Peter Hammond ◽  
Pratik Choudhary

The number of children and adults with Type 1 diabetes on insulin pump therapy in the UK continues to rise. However, there remains significant geographical variation in uptake. It is likely that health care professional training is a key factor driving this variation. In response, the Diabetes Technology Network UK has developed a national best practice guide to support health care professionals to develop and maintain their skills in insulin pump therapy. An overview of this guide is provided


2020 ◽  
Vol 35 (5) ◽  
pp. 254-259
Author(s):  
Leah Wyckoff ◽  
Cari Berget

The advantages of continuous glucose monitoring (CGM) and insulin pump systems have increased the popularity of these devices among students in the school setting. The use of diabetes technology at school and school-sponsored activities strengthens the student’s consistent use of the technology and increases the overall beneficial effects. The school nurse has many considerations when supporting the student with diabetes technology. Integrating this technology into diabetes care at school can be complex with collaboration and safety considerations fundamental to success. This is the third article in a three-part series on the use of technology in managing diabetes in youth. The first article described CGM devices and provided tips for the school nurse in incorporating CGM into the student’s individualized healthcare plan. The second article summarized insulin pump technologies, from conventional insulin pump therapy to advance automated insulin delivery systems and described keys to success with insulin pump technologies. The purpose of this article is to address some special considerations for facilitating the use of diabetes technology in the school setting. Topics to be discussed are tips on including insulin pump therapy in the student’s individualized healthcare plan, safe use of diabetes technology during physical activity, and implications for school nursing practice.


Author(s):  
Sanja Minic ◽  
Sanja Medenica ◽  
Emir Muzurovic ◽  
Sreten Kavaric ◽  
Aleksandar Djogo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document